| Series
Calendar: |
| 4/6/2005
|
Dr. Michael Dean |
Cyclopamine, A Drug Targeting the Hedgehog/Patched Pathway and Perhaps Tumor Stem Cells |
| 3/2/2005
|
Dr. David Roberts |
Molecular Targets for Angiogenesis Inhibitors |
| 1/5/2005
|
Dr. Dao Nguyen |
Development of Apo2L/TRAIL as a Novel Therapy for Thoracic Cancer |
| 12/6/2004
|
Dr. Massimo Zollo |
Unravelling h-prune Function Together with nm23 Family Proteins, a New Potential Therapeutic Target |
| 12/1/2004
|
Dr. William Farrar |
STAT3-Target Validation and Strategies For Intervention |
| 11/17/2004
|
Dr. William Figg |
Development of Thalidomide Analogs---What Are the Next Steps? |
| 10/6/2004
|
Dr. Constantine Mitsiades |
Therapeutic Implications of IGF-1R Inhibition in Human Neoplasias |
| 7/7/2004
|
Dr. Chris Michejda |
Cell Surface Proteins as Targets for Cancer Therapy |
| 6/2/2004
|
Dr. Jane Trepel |
Inhibition of Tumor Cell Motility and Metastasis by the Interferon-Inducible GTPase MxA |
| 3/3/2004
|
Larry Keefer |
CANCELLED Therapeutic Applications of Nitric Oxide Prodrugs |
| 2/4/2004
|
Jane Trepel |
Inhibition of Tumor Cell MOtility and Metastatic by the Interferon-inducible GTPase MxA |
| 1/7/2004
|
Sandra Swain |
Evaluation of EGFR Signaling in Tumor and Normal Tissues After Treatment with Erlotinib (OSI-774) in Patients with Metastasic Breast Cancer |
| 1/7/2004
|
Sandy Swain |
Evaluation of EGFR Signaling in Tumor and Normal Tissues After Treatment with Erlotinib (OSI-774) in Patients with Metastatics Breast Cancer |
| 12/3/2003
|
Thomas Sayers |
Combination of PS-341 (velcade) and TRAIL for Cancer Therapy |
| 11/5/2003
|
Daniel Jay |
Functional Proteomics to Identify Proteins in Tumor Cell Invasion |
| 10/1/2003
|
Peter Blumberg |
Emerging Insights into the Pharmacology of Vanilloid (Capsaicin) Receptors, A Therapeutic Target for Pain and Other Applications |
| 8/6/2003
|
Denise Perry Simmons |
Lecithin: Retinol Acyltransferase, Tazarotene-Induced Gene, and Revertant 107 Peptides' Design and Potential Use as Molecular Probes and Therapies in Human Cutaneous Melanoma |
| 5/7/2003
|
William L. Farrar, PhD |
Suppression of Breast Carcinoma by Chemical Modulation of Vulnerable Zinc Fingers within Estrogen Receptor DNA Binding Domains |
| 4/2/2003
|
Susan Bates, M.D., Cancer Therapeutics Branch |
The Role of Depsipeptide, a Histone Deacetylase Inhibitor in the Treatment of T Cell "Lymphoma" |
| 3/5/2003
|
Anita B Roberts |
Smad3: An Important Target in Modulating Pathogenesis of TGF-beta |
| 1/31/2003
|
Albert Zlotnik
|
A Link between Chemokines and Cancer
The Use of Gene Arrays to Identify Genes That are Expressed in Cancers |
| 1/8/2003
|
Nancy H. Colburn, Ph.D.; Charles R. Vinson, Ph.D. |
Molecular Targets Faculty Seminar - AP1/Jun/Fos as a Molecular Target |
| 1/8/2003
|
Drs. Nancy H. Colburn and Charles R. Vinson |
Molecular Targets Faculty Seminar - AP1/Jun/Fos as a Molecular Target |
